Neha Vapiwala, MD
Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 4 de noviembre del 2005
May 22, 2015 - Figitumumab -- a fully human IgG2 monoclonal antibody -- appears safe for use in sarcoma, with observable anti-tumor activity, according to research published online Dec. 24 in The Lancet Oncology.
May 22, 2015
Jul 13, 2010